241 related articles for article (PubMed ID: 31328070)
1. Spontaneous Tumor Lysis Syndrome in Diffuse Large B-cell Lymphoma: Early Diagnosis and Management.
Gangireddy M; Shrimanker I; Nookala VK; Peroutka KA
Cureus; 2019 May; 11(5):e4679. PubMed ID: 31328070
[TBL] [Abstract][Full Text] [Related]
2. A Needle in the Haystack: A Rare Case of Spontaneous Tumor Lysis in Newly Diagnosed Chronic Lymphocytic Leukemia Unmasked by Acute Renal Failure.
Desai M; Parsi M; Potdar R; Sanjay R
Cureus; 2020 Oct; 12(10):e11279. PubMed ID: 33274154
[TBL] [Abstract][Full Text] [Related]
3. A rare case of spontaneous tumor lysis syndrome in multiple myeloma.
Aldabain L; Camire L; Weisman DS
J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):365-368. PubMed ID: 32850100
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of hyperuricemia in hematological malignancies.
Cairo MS
Clin Lymphoma; 2002 Dec; 3 Suppl 1():S26-31. PubMed ID: 12521386
[TBL] [Abstract][Full Text] [Related]
5. Massive hyperphosphatemia in clinical tumor lysis syndrome during prophylactic rasburicase use: risk factors and treatment options.
Kikuchi S; Muro M; Kamihara Y; Wada A; Murakami J; Nabe Y; Minemura T; Sato T
Int Cancer Conf J; 2023 Jan; 12(1):69-74. PubMed ID: 36605847
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous tumor lysis syndrome in a patient with metastatic prostate cancer.
Serling-Boyd N; Quandt Z; Allaudeen N
Mol Clin Oncol; 2017 Apr; 6(4):589-592. PubMed ID: 28413674
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
[TBL] [Abstract][Full Text] [Related]
8. Rasburicase in cancer-related hyperuricemia.
Rodriguez M; Campara M; Haaf C
Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous Tumor Lysis Syndrome Secondary to Metastatic Small Cell Lung Cancer.
Koura S; Parekh V; Parikh AD; Kaur K; Dunn BK
Cureus; 2023 Feb; 15(2):e34557. PubMed ID: 36879689
[TBL] [Abstract][Full Text] [Related]
10. A Rare Syndrome in a Rare Carcinoma: A Case of Spontaneous Tumor Lysis Syndrome in Small-Cell Liver Carcinoma.
Aina DA; Erwin A; Li E; Manam R
Cureus; 2023 Feb; 15(2):e35455. PubMed ID: 36994306
[TBL] [Abstract][Full Text] [Related]
11. Rasburicase for the treatment of tumor lysis in hematological malignancies.
Malaguarnera G; Giordano M; Malaguarnera M
Expert Rev Hematol; 2012 Feb; 5(1):27-38. PubMed ID: 22272702
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.
Alakel N; Middeke JM; Schetelig J; Bornhäuser M
Onco Targets Ther; 2017; 10():597-605. PubMed ID: 28203093
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperuricemia with rasburicase review.
de Bont JM; Pieters R
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature.
Shafie M; Teymouri A; Parsa S; Sadeghian A; Zarei Jalalabadi N
J Med Case Rep; 2022 Feb; 16(1):52. PubMed ID: 35139902
[TBL] [Abstract][Full Text] [Related]
15. Tumor Lysis Syndrome Rare Presentation As Uremic Pericarditis: A Case Report.
Caleça Emidio F; Pereira R; Martins Dos Santos P; Abegão T
Cureus; 2023 Mar; 15(3):e35727. PubMed ID: 36875257
[TBL] [Abstract][Full Text] [Related]
16. [Tumor lysis syndrome: risk factors and treatment].
Hörl WH
Wien Klin Wochenschr; 2005 Jan; 117(1-2):7-17. PubMed ID: 15986584
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma.
Infante J; Casado A; Almeida A; Messias A
J Hematol; 2021 Feb; 10(1):30-34. PubMed ID: 33643508
[TBL] [Abstract][Full Text] [Related]
18. The management of tumor lysis syndrome.
Rampello E; Fricia T; Malaguarnera M
Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous Tumor Lysis Syndrome in an Adenocarcinoma of Unknown Origin.
Kalter JA; Allen J; Yang Y; Willing T; Evans E
Cureus; 2020 Dec; 12(12):e12169. PubMed ID: 33489580
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens.
Weeks AC; Kimple ME
J Investig Med High Impact Case Rep; 2015; 3(3):2324709615603199. PubMed ID: 26904699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
